InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Hatfield Jeffrey S., 董事. Officer active across 2 companies, notably Vir Biotechnology, Inc.. Aggregated, 6 reports have been logged. History available since 21 May 2021. The latest transaction was filed on 30 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hatfield Jeffrey S.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
8,000 股0Common StockSEC:0001628280-25-028892:0
8,000 股0Common StockSEC:0001628280-24-026193:0
6,027 股0Common StockSEC:0001209191-23-031841:0
6,405 股0Common StockSEC:0001209191-22-031949:0
3,374 股0Common StockSEC:0001209191-21-035706:0
26,537 股Common StockSEC:0001104659-16-091215:0
6 条申报中的 6 条
About Hatfield Jeffrey S.
Jeffrey S. Hatfield is a Director at Vir Biotechnology, Inc. As a board member, he participates in overseeing operations and strategic decision-making. His experience is valuable in guiding the company's direction.
